期刊
CELL
卷 148, 期 6, 页码 1160-1171出版社
CELL PRESS
DOI: 10.1016/j.cell.2012.02.010
关键词
-
资金
- Wellcome Trust
- MRC
- Royal Society
- Diabetes UK
- Medical Research Council [G0801995] Funding Source: researchfish
- Wellcome Trust [095531/Z/11/Z] Funding Source: researchfish
- MRC [G0801995] Funding Source: UKRI
- Wellcome Trust [095531/Z/11/Z] Funding Source: Wellcome Trust
Diabetes is a major global problem. During the past decade, the genetic basis of various monogenic forms of the disease, and their underlying molecular mechanisms, have been elucidated. Many genes that increase type 2 diabetes (T2DM) risk have also been identified, but how they do so remains enigmatic. Nevertheless, defective insulin secretion emerges as the main culprit in both monogenic and polygenic diabetes, with environmental and lifestyle factors, via obesity, accounting for the current dramatic increase in T2DM. There also have been significant advances in therapy, particularly for some monogenic disorders. We review here what ails the beta cell and how its function may be restored.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据